Table 2. Quality assessment of included studies.
| Item/study | Farrokhi Karibozorg (2018) | Lu (2015) | Menezes (2010) | Mostowska (2012) | Nikopensius (2010) | Rafighdoost (2018) | Xin (2013) |
|---|---|---|---|---|---|---|---|
| Adequate definition of cases | * | * | * | * | * | * | * |
| Representativeness of cases | - | - | - | - | - | - | - |
| Selection of control subjects | - | - | - | - | * | - | - |
| Definition of control subjects | * | * | * | * | * | * | * |
| Control for important factor or additional factor | * | - | - | ** | - | ** | - |
| Exposure assessment | * | * | * | * | * | * | * |
| Same method of ascertainment for all subjects | * | * | * | * | * | * | * |
| Non-response rate | * | * | * | * | * | * | * |
A study could be awarded a maximum of one star for each item except for the item ‘Control for important factor or additional factor’.
The definition/explanation of each column of the NOS is available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.